Andrew Brown
Has grant
Principal Investigator
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Consortium Against Pain inEquality (CAPE) - The impact of adverse childhood experiences on chronic pain and responses to treatment
Open Date: 2021-06-30
Close Date: 2026-06-29
Grant: Close
Genetic control of brain function: a statistical pathway approach into the molecular basis of psychosis
Open Date: 2011-01-01
Close Date: 2015-12-31
Articles (8)
Many non-coding variants influence complex traits and diseases through gene regulation, yet the mechanisms linking these variants to downstream biology remain poorly understood. Here, we present eQTLGen Phase 2 , a comprehensive genome-wide analysis of gene expression quantitative trait loci (eQTLs) in 43,301 blood samples from 52 datasets. Beyond local cis -effects, this sample size enabled the first systematic mapping of trans -eQTLs at scale. We identify cis -eQTLs for nearly all expressed genes (94.7%) and trans -eQTLs for over half (56.2%). Second, by colocalizing cis -eQTLs with trans -eQTLs, we infer a directed gene regulatory network comprising 47,554 directed gene regulatory relationships. These networks reveal how genetic perturbations in upstream regulators produce dose-dependent downstream effects, supported by Perturb-seq and ChIP-seq data. Third, integrating this network with 87 genome-wide association studies allows us to systematically prioritize trait-relevant pathways and candidate genes. Variants exerting both cis – and trans -effects are markedly more likely to colocalize with trait associations than cis -only variants, delineating a subset of functionally active cis -eQTLs from a large group with limited downstream impact. This distinction provides a conceptual framework for identifying regulatory variants that truly mediate complex trait biology. Together, these results provide a publicly available resource of cis – and trans -eQTLs and an in vivo scaffold for human gene-regulatory networks, elucidating how propagation of cis -effects modulates complex disease.
Year:
2026
Year:
2025
Year:
2024
Identification of genes and proteins mediating the activity of GWAS variants requires molecular data from disease relevant tissues, but these may be difficult to collect. Using multiple gene expression reference datasets and GWAS summary statistics for T2D we identified 1,818 unique genes associated with T2D. Comparing the performance of different reference datasets, we found that sample size, and not the relevance of the tissue to the disease, was the critical factor in identifying relevant genes. Genes implicated using a well powered expression dataset were also more likely to have multiple lines of genetic evidence. A targeted proteomics reference dataset from plasma samples showed similar power to identify T2D related proteins as gene expression with the same sample size. Accounting for BMI reduces power across all tissues and phenotypes by ∼30%, suggesting that many GWAS links to T2D are mediated by BMI, potentially implicating insulin resistance related effects. Finally, using data from smaller GWAS studies with precisely defined T2D subtypes uncovers genes directly relevant to that subtype, such as LST1 , an immune response gene for Severe Autoimmune Diabetes and TRMT2A , involved in beta-cell apoptosis, for Severe Insulin Deficient Diabetes. Our work demonstrates the benefits of well powered reference datasets in accessible tissues and well-defined disease subtypes when studying complex diseases involving multiple tissues.
Year:
2024
The production of multiple transcripts per gene is a process regulated by inherited genetic variants and epitranscriptomic modifications, and plays a prominent role in modulating complex traits and diseases. To simultaneously characterize the effect of genetic variants on transcript abundance and N6-methyladenosine (m6A) modifications, we produced long-read native poly(A) RNA-seq data for 60 genetically different lymphoblastoid cell lines (LCLs) from the 1000 Genomes/Geuvadis project. We identified a high diversity of both annotated (31%) and unannotated (61%) transcripts, with only a small proportion expressed across individuals (35% and 7%, respectively). In a genome-wide genetic analysis on transcripts, we identified 105 trQTLs, of which 76 were not detected as eQTLs using a larger published short-read RNAseq dataset (317 samples). A population wide characterization of m6A methylation DRACH motifs identified an average of 40.1 m6A modifications on 6,222 genes. Genetic association analysis of highly variable modifications from 1,155 genes identified m6A modification quantitative trait loci (m6A-QTLs) for 16 transcripts. Colocalization analysis of trQTL and m6A-QTLs, identified 33 candidate transcripts mediating GWAS traits, with 46.4% of the colocalized trQTLs implicating novel risk transcripts. Overall, the simultaneous characterization of transcripts and post-transcriptional modifications identified genetic effects on transcription often missed when using other sequencing technologies.
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (65)
Qingbo Wang
Associate Professor
University of Tokyo
Annique Claringbould
Assistant Professor
Erasmus MC
Marie Loh
Assistant Professor
Lee Kong Chian School of Medicine
Konstantinos Tsirigos
Technical University of Denmark
Javier Martin
Professor
Instituto de Parasitología y Biomedicina López-Neyra
Katie Burnham
University of Oxford
Sini Nagpal
Assistant Professor
Indian Institute of Technology, Bombay
Brenda WJH Penninx
Professor
-
Hae Kyung Im
University of Chicago
René Pool
University of Amsterdam
Markus Scholz
Leipzig University
Farzana Jasmine
Staff Scientist
University of Chicago
Jochen M Schwenk
KTH Royal Institute of Technology
Paul Franks
Professor
Lund University Medical Faculty Foundation
Marta Eugenia Alarcón Riquelme
Scientific Director
Centro Pfizer - Universidad de Granada - Junta de Andalucía de Genómica e Investigación Oncológica
Laura Raffield
Assistant Professor
University of North Carolina at Chapel Hill
Dirk Paul
Interim Head of PMB BioPharma
AstraZeneca UK Limited
Tue Hansen
Københavns Universitet
Colin Palmer
Academic, Professor (Teaching and Research) of Pharmacogenomics
University of Dundee
Jouke-Jan Hottenga
Senior Researcher
Hamad Bin Khalifa University
Roel A. Ophoff
Professor
University of California, Los Angeles
Ana Viñuela
Academic, Lecturer (Teaching and Research)
University of Dundee
Ewan Pearson
Academic, Clinical Professor (Teaching and Research) of Diabetic Medicine
University of Dundee
Pashupati Mishra
Tampere University
Cecilia Engel Thomas
Københavns Universitet
Emma Elisabeth Davenport
Group Leader
Wellcome Sanger Institute
Oluf Pedersen
Professor and Chief Research Physician
Københavns Universitet
José Manuel Soria Fernández
Principal Investigator. Head of Group
Hospital de la Santa Creu i Sant Pau
Julian Knight
University of Oxford
Mika Kähönen
University of Tampere
Muhammad Kibriya
Research Associate Professor
University of Chicago
Alexander Teumer
Professor
University Medicine Greifswald
Toni Boltz
Massachusetts General Hospital
Angus Jones
Clinical Professor (Associate Clinical Professor to 07/2024)
University of Exeter
Torben Hansen
Københavns Universitet
Zoltán Kutalik
Full Professor
University of Lausanne
Mark Haid
Head Of Lipidomics Platform
-
Katja Pahkala
Associate professor, Academy research fellow
University of Turku
Emma Raitoharju
Senior Researcher
University of Tampere
Grant Montgomery
Professorial Research Fellow
University of Queensland
Federico De Masi
Technical University of Denmark
Annette Peters
Chair of Epidemiology
Ludwig-Maximilians-Universität München
Kaur Alasoo
Associate Professor
University of Tartu
Joachim Thiery
Dean of Medicine and UKSH Board for Research snd Education
Kiel University
Alexis Battle
Professor
Johns Hopkins University
Holger Kirsten
Leipzig University
Olli T. Raitakari
University of Turku
Mark Walker
Professor of Molecular Diabetic Medicine
Newcastle University
Uwe Völker
Professor, Head of Department
Universitätsmedizin Greifswald
Jan Veldink
Professor of Neurology and Neurogenetics
University Medical Center Utrecht, Utrecht University
Henrik Vestergaard
Københavns Universitet
Suvi Rovio
Adjunct professor, senor researcher
University of Turku
Carlos Cruchaga
Professor
Washington University in St. Louis
Carla van der Kallen
University of Maastricht
Yong Fan
Professor
Københavns Universitet
Terho Lehtimäki
University of Tampere
Greg Gibson
Regents Professor
Georgia Tech
Yukinori Okada
University of Tokyo
Marleen van Greevenbroek
University of Maastricht
Agnete Troen Lundgaard
Hvidovre Hospital
Yun Li
Professor
University of North Carolina
Anna Jonsson
Københavns Universitet
Dorret I Boomsma
Full professor
University of Amsterdam
Line Engelbrechtsen
Consultant, Associate Professor, MD, PhD
Herlev Hospital
Takanori Hasegawa
Associate Professor
Institute of Science Tokyo
Make your next move.
Prepare your application
Review drafts before you send them.